Japan Lifeline Co., Ltd.
Japan Lifeline Q1 Earnings for FY2027｜Sales of ¥15.9 billion (up 8.8% YoY)
Japan Lifeline achieved sales of ¥15.9 billion (up 8.8% YoY) in the first quarter of FY2027, with net profit of ¥230 million (almost flat). The company recorded record highs driven by new products and overseas expansion, despite a decrease in operating profit due to increased R&D expenses.
Key Figures
- Sales: ¥15.9 billion (up 8.8% YoY)
- Net income attributable to owners of parent: ¥230 million (almost flat)
- Operating profit: ¥2.97 billion (down 9.4% YoY)
AI要約
Performance Overview
Japan Lifeline recorded sales of ¥15.9 billion (up 8.8% YoY) in the first quarter of FY2027, reaching an all-time high. Growth was driven by expanded sales of new products and expansion into overseas markets, while operating profit declined due to increased R&D expenses. Net income remained relatively unchanged, indicating a stable revenue base. The expanding demand for medical devices and entry into new areas are key to future growth.
Outlook and Shareholder Impact
The company maintains its full-year earnings forecast for FY2027 and has revised its dividend outlook to an interim dividend of 25 yen and a year-end dividend of 56 yen, totaling 81 yen. It aims to expand sales through overseas development and new product launches, while continuing to invest in R&D for long-term growth. The company plans to increase dividends as a shareholder return measure, responding to investor expectations.
Japan Lifeline Co., Ltd.
Company overview · Stock price · Financial data · All IR
